Sponsor Pipeline

National Cancer Institute, Slovakia Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
Active Trials by Phase
Phase 2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07121322 Dornase Alfa and Cisplatin in Refractory Germ Cell Cancer. Refractory Germ Cell Tumors Recruiting
Not specified
NCT04691284 Microbiome in Cancer Patients With High Dose Chemotherapy With Stem Cell Transplantation Hematologic Neoplasms Recruiting
Get alerts when National Cancer Institute, Slovakia's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free